Autophagy in major human diseases

DJ Klionsky, G Petroni, RK Amaravadi… - The EMBO …, 2021 - embopress.org
Autophagy is a core molecular pathway for the preservation of cellular and organismal
homeostasis. Pharmacological and genetic interventions impairing autophagy responses …

Metabolism and mitochondria in polycystic kidney disease research and therapy

V Padovano, C Podrini, A Boletta… - Nature Reviews …, 2018 - nature.com
Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common,
potentially lethal, monogenic diseases and is caused predominantly by mutations in …

Nutrient-sensing mTORC1 and AMPK pathways in chronic kidney diseases

C Huynh, J Ryu, J Lee, A Inoki, K Inoki - Nature Reviews Nephrology, 2023 - nature.com
Nutrients such as glucose, amino acids and lipids are fundamental sources for the
maintenance of essential cellular processes and homeostasis in all organisms. The nutrient …

Emerging role of autophagy in kidney function, diseases and aging

TB Huber, CL Edelstein, B Hartleben, K Inoki, M Jiang… - Autophagy, 2012 - Taylor & Francis
Autophagy is a highly conserved process that degrades cellular long-lived proteins and
organelles. Accumulating evidence indicates that autophagy plays a critical role in kidney …

[HTML][HTML] Autophagy in kidney disease and aging: lessons from rodent models

O Lenoir, PL Tharaux, TB Huber - Kidney international, 2016 - Elsevier
Autophagy is a highly regulated lysosomal protein degradation pathway that removes
protein aggregates and damaged or excess organelles to maintain intracellular homeostasis …

Autophagy in kidney disease

ME Choi - Annual review of physiology, 2020 - annualreviews.org
Autophagy is a cellular homeostatic program for the turnover of cellular organelles and
proteins, in which double-membraned vesicles (autophagosomes) sequester cytoplasmic …

Indoxyl sulfate contributes to mTORC1-induced renal fibrosis via the OAT/NADPH oxidase/ROS pathway

T Nakano, H Watanabe, T Imafuku, K Tokumaru, I Fujita… - Toxins, 2021 - mdpi.com
Activation of mTORC1 (mechanistic target of rapamycin complex 1) in renal tissue has been
reported in chronic kidney disease (CKD)-induced renal fibrosis. However, the molecular …

Apoptosis and autophagy in polycystic kidney disease (PKD)

KL Nowak, CL Edelstein - Cellular signalling, 2020 - Elsevier
Apoptosis in the cystic epithelium is observed in most rodent models of polycystic kidney
disease (PKD) and in human autosomal dominant PKD (ADPKD). Apoptosis inhibition …

Diagnosis and management of childhood polycystic kidney disease

WE Sweeney, ED Avner - Pediatric nephrology, 2011 - Springer
A number of syndromic disorders have renal cysts as a component of their phenotypes.
These disorders can generally be distinguished from autosomal dominant polycystic kidney …

Folate-conjugated rapamycin slows progression of polycystic kidney disease

JM Shillingford, CP Leamon, IR Vlahov… - Journal of the …, 2012 - journals.lww.com
Activation of the mammalian target of rapamycin (mTOR) signaling pathway is aberrant in
autosomal-dominant polycystic kidney disease (ADPKD). The mTOR inhibitors, such as …